RT Journal Article
SR Electronic
T1 Impacts of COVID-19 public measures on country-level trade flows: Global panel regression analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.09.21260294
DO 10.1101/2021.07.09.21260294
A1 Sylvia Szabo
A1 Worawat Srisawasdi
A1 Takuji W Tsusaka
A1 Reuben M.J. Kadigi
A1 James Vause
A1 Neil D. Burgess
YR 2021
UL http://medrxiv.org/content/early/2021/07/24/2021.07.09.21260294.abstract
AB As of 10 July 2021, there have been over 186 million cases of COVID-19 and more than four million died as a result of this disease. The COVID-19 outbreak has also contributed to tremendous global decline in trade flows. The rapid spread of COVID-19 and the measures implemented by governments to contain the pandemic have had serious consequences for the world’s economies. While the pandemic has affected the international movement of people, goods and services, there is still limited systematic research regarding the possible associations between the COVID-19 measures on countries’ international trade flows. To fill this gap, we conducted regression analysis based on country level time series data from the United Nations and World Bank datasets. The results of the random effects panel regression models show that, the country import and export values are positively affected by health-related policies, while there is a negative association between stringency measures and import and export values. More specifically, school closing, stay-at-home requirements, and testing policy measures were found to have significant negative effects on countries’ trade values. In contrast, facial covering policies were found to have significant positive effects on countries’ import, export and total trade values.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research was conducted as part of the UKRI GCRF Trade, Environment and Development Project led by the World Conservation Monitoring Centre.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB irrelevant.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data can be provided upon request.